108 related articles for article (PubMed ID: 23201546)
21. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
Yao DM; Qian J; Lin J; Wang YL; Chen Q; Qian Z; Li Y; Wang CZ; Yang J
Leuk Res; 2011 Jul; 35(7):957-60. PubMed ID: 21106240
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
23. [Expression of SALL4 and BMI-1 mRNA in acute leukemia].
Tang P; Sun H; Liu YF; Wang GY; Yin YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1271-4. PubMed ID: 19099625
[TBL] [Abstract][Full Text] [Related]
24. MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia.
Qian J; Chen Q; Yao DM; Yang L; Yang J; Wen XM; Zhang YY; Chai HY; Ma JC; Deng ZQ; Lin J
Int J Clin Exp Pathol; 2015; 8(1):127-36. PubMed ID: 25755699
[TBL] [Abstract][Full Text] [Related]
25. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
[TBL] [Abstract][Full Text] [Related]
27. The Study of SALL4 Gene and BMI-1 Gene Expression in Acute Myeloid Leukemia Patients.
Swelem RS; Elneely DA; Shehata AAR
Lab Med; 2020 May; 51(3):265-270. PubMed ID: 31552409
[TBL] [Abstract][Full Text] [Related]
28. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
29. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
Chim CS; Tam CY; Liang R; Kwong YL
Cancer; 2001 Jun; 91(12):2222-9. PubMed ID: 11413509
[TBL] [Abstract][Full Text] [Related]
30. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.
Shimamoto T; Ohyashiki JH; Ohyashiki K
Leuk Res; 2005 Jun; 29(6):653-9. PubMed ID: 15863205
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia.
Xu Z; Wang M; Wang L; Wang Y; Zhao X; Rao Q; Wang J
Leuk Res; 2009 Jul; 33(7):891-7. PubMed ID: 19250671
[TBL] [Abstract][Full Text] [Related]
32. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
Benetatos L; Hatzimichael E; Dasoula A; Dranitsaris G; Tsiara S; Syrrou M; Georgiou I; Bourantas KL
Leuk Res; 2010 Feb; 34(2):148-53. PubMed ID: 19595458
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes.
Shuai X; Zhou D; Shen T; Wu Y; Zhang J; Wang X; Li Q
Cancer Genet Cytogenet; 2009 Oct; 194(2):119-24. PubMed ID: 19781444
[TBL] [Abstract][Full Text] [Related]
34. Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia.
Fuster O; Barragán E; Bolufer P; Such E; Valencia A; Ibáñez M; Dolz S; de Juan I; Jiménez A; Gómez MT; Buño I; Martínez J; Cervera J; Montesinos P; Moscardó F; Sanz MÁ
Ann Hematol; 2012 Jan; 91(1):1-7. PubMed ID: 21538063
[TBL] [Abstract][Full Text] [Related]
35. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
36. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
Wang J; Wang T; Li S; Lin L; Gang Y
Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemia.
Zhou JD; Wen XM; Zhang YY; Yang L; Ma YJ; Ma JC; Yang J; Guo H; Yao DM; Lin J; Qian J
Int J Clin Exp Pathol; 2015; 8(3):2384-91. PubMed ID: 26045745
[TBL] [Abstract][Full Text] [Related]
38. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia.
Mori N; Yoshinaga K; Tomita K; Ohwashi M; Kondoh T; Shimura H; Wang YH; Shiseki M; Okada M; Motoji T
Leuk Res; 2011 Apr; 35(4):516-21. PubMed ID: 20828818
[TBL] [Abstract][Full Text] [Related]
39. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
[TBL] [Abstract][Full Text] [Related]
40. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
Hájková H; Marková J; Haškovec C; Sárová I; Fuchs O; Kostečka A; Cetkovský P; Michalová K; Schwarz J
Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]